Filing Flows › Stemtech (STEK) › Q2 2026
Stemtech (STEK) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Stemtech (STEK) reported revenue of $629K for the second quarter 2026 (Q2 2026), -10% from a year earlier and +36% from the quarter before. Operating margin was -20.0%, net loss $292K (46.5% of revenue).
Stemtech, Q2 2026: revenue $629K (-10% year over year), operating margin -20.0%, net loss $292K, operating cash flow −$55K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $629K | +36% | -10% |
| Operating profit | −$126K | — | — |
| Net earnings | −$292K | — | — |
| Operating cash flow | −$55K | — | -173% |
What changed
Revenue was $629K in Q2 2026, down 10% year over year and up 36% from the previous quarter.
Gross margin was 74.0%, down 5.1 points from Q2 2025. Operating costs exceeded revenue by $126K, an operating margin of -20.0%. Operating expenses fell 31% while revenue fell 10%. The quarter ended with a net loss of $292K, narrower than the previous quarter's $1.3M loss. Net interest and other expense of $167K was the main reason.
Operating cash flow was −$55K. Non-cash charges added back $42K of depreciation and amortization and $109K of share-based compensation. Working capital and other items added $86K.
Questions
What was Stemtech's revenue in the second quarter 2026?
Stemtech (STEK) reported revenue of $629K for the second quarter 2026 (Q2 2026), -10% from a year earlier and +36% from the quarter before.
Was Stemtech profitable in the second quarter 2026?
Operating loss was $126K (-20.0% of revenue) and net loss $292K.
Source: Stemtech 10-Q on SEC EDGAR.